Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Leukemia & Lymphoma|March 28, 2015
Clinical features of life-threatening complications following autologous stem cell transplantation in patients with lymphomaLionel Kerhuel, Sandy Amorim, Elie Azoulay, et al.Blood|August 5, 2015
Activity of ibrutinib in mantle cell lymphoma patients with central nervous system relapseSophie Bernard, Lauriane Goldwirt, Sandy Amorim, et al.Leukemia & Lymphoma|August 8, 2014
Outcomes after intensive care unit admission of patients with newly diagnosed lymphomaCaroline Algrin, Stanislas Faguer, Virginie Lemiale, et al.Annals of Hematology|September 16, 2018
Intensive care unit admission in patients with T cell lymphomas: clinical features and outcomeGuillaume Dumas, Lucie Biard, Claire Givel, et al.Journal of Thoracic Imaging|May 16, 2015
Diagnostic Yield and Safety of Computed Tomography-guided Mediastinal Core Needle BiopsiesConstance de Margerie-Mellon, Cédric de Bazelaire, Sandy Amorim, et al.Leukemia & Lymphoma|October 28, 2014
Management and prognosis of 66 patients with B-cell non-Hodgkin lymphoma presenting with initial spinal cord compression: a French retrospective multicenter studyIsabelle Fleury, Sandy Amorim, Nicolas Mounier, et al.European Journal of Cancer (Oxford, England : 1990)|July 24, 2017
Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC studyAlexandre Morel, Josette Brière, Laurence Lamant, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 28, 2017
The value of molecular techniques to diagnose Ureaplasma urealyticum and Nocardia farcinica pleuropneumonia in a patient with diffuse large B-cell lymphomaEtienne Canouï, Kim Blanc, Julien Loubinoux, et al.The Lancet. Oncology|July 22, 2014
Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b studyAnas Younes, Catherine Thieblemont, Franck Morschhauser, et al.Pageof 3